Evidence map›Paper›PMID 36294831›Full record

ArticleJournal of personalized medicine2022

Daily Physical Activity in Asthma and the Effect of Mepolizumab Therapy.

Marios Panagiotou, Nikolaos Koulouris, Antonia Koutsoukou, Nikoletta Rovina

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Patient-centred outcomes in severe asthma: fatigue, sleep, physical activity and work.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Marios Panagiotou1st Department of Respiratory Medicine, Medical School, National and Kapodistrian University of Athens, "Sotiria" Chest Disease Hospital, 115 27 Athens, Greece.
Nikolaos Koulouris1st Department of Respiratory Medicine, Medical School, National and Kapodistrian University of Athens, "Sotiria" Chest Disease Hospital, 115 27 Athens, Greece.
Antonia Koutsoukou1st Department of Respiratory Medicine, Medical School, National and Kapodistrian University of Athens, "Sotiria" Chest Disease Hospital, 115 27 Athens, Greece.
Nikoletta Rovina1st Department of Respiratory Medicine, Medical School, National and Kapodistrian University of Athens, "Sotiria" Chest Disease Hospital, 115 27 Athens, Greece.ORCID 0000-0003-0138-5582
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For the various asthma-specific beneficial effects of physical activity, daily physical activity (DPA) and the potential of asthma therapies on DPA require better characterization. Hence, we aimed to determine (a) the DPA of asthma patients, and (b) the effect of add-on mepolizumab on the DPA of severe asthma patients.

Indexed as

accelerometerasthmadaily physical activityguidelinesmepolizumabmoderate-to-vigorous physical activity (MVPA)movement intensitysevere asthmastep count

Identifiers

PMID36294831
PMCPMC9605576
OpenAlexW4304184904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.